Background: Gut microbiota is reported to be related to the onset of insulin resistance (IR) and type 2 diabetes mellitus (T2DM). The dietary index for gut microbiota (DI-GM) is a novel index for reflecting gut microbiota diversity. We aimed to evaluate the association of DI-GM with T2DM and IR.Methods: This cross-sectional research comprised 10,600 participants aged ≥20 from the National Health and Nutrition Examination Survey (NHANES) 2007–2018. We employed weighted multivariable linear and logistic regression models to examine the correlation of DI-GM with T2DM and IR. Linear or nonlinear relationships were examined by restricted cubic spline (RCS) regression. Additionally, subgroup and sensitivity analyses were performed to ensure the reliability of the results. Mediation analysis explored the roles of body mass index (BMI) and inflammatory factors in these associations.Results: Higher DI-GM were inversely associated with T2DM (OR = 0.93, 95%CI: 0.89–0.98) and IR (OR = 0.95, 95%CI: 0.91–0.99) after adjusting for confounders. DI-GM ≥ 6 group showed significantly lower risks of T2DM (OR = 0.74, 95%CI: 0.60–0.91) and IR (OR = 0.77, 95%CI: 0.62–0.95). RCS demonstrated a linear relationship between DI-GM and T2DM, as well as IR. DI-GM was also inversely correlated with the risk markers of T2DM. Mediation analysis showed that BMI and the systemic inflammation response index partly mediated the association of DI-GM with T2DM and IR, while the systemic immune-inflammation index mediated only the association with T2DM.Conclusion: DI-GM is inversely associated with T2DM and IR, with BMI and inflammatory markers partly mediating this association.
Background: This study analyzes the correlation between oxidative balance score (OBS), cardiometabolic risk factors (CMRFs), and mortality in individuals with CMRFs. Methods: Data were chosen from the National Health and Nutrition Examination Survey. The survey-weighted multivariable logistic regression models were implemented to explore the relationship between OBS and the risk of CMRFs. Then, Cox proportional hazard models were employed to estimate the impact of OBS on mortality in individuals with CMRFs. Results: Following multivariate adjustment, the subjects in the highest quartile exhibited a 46% reduction in the risk of CMRFs, a 33% reduction in the risk of diabetes, a 31% reduction in the risk of hypertension, and a 36% reduction in the risk of hyperlipidemia, compared with those in the lowest quartile. Furthermore, each 1-unit increase in OBS was remarkably negatively correlated with the prevalence of CMRFs, diabetes, hypertension, and hyperlipidemia. The correlation between OBS and CMFRs was found to be mediated by serum γ-glutamyltransferase (GGT) and white blood cells (WBC), and the mediation effect of GGT levels and WBC, accounting for 6.90% and 11.51%, respectively. Lastly, the multivariate Cox regression model revealed that elevated OBS, irrespective of whether it was treated as a categorical or continuous variable, exhibited a significant association with decreased mortality from all causes, cardiovascular disease, and cancer. Conclusions: An increased OBS might reflect a lower risk of CMRFs and a favorable prognosis for individuals with CMRFs. Moreover, WBC and GGT may play a potential mediating role between OBS and CMRFs.
Esophageal squamous cell carcinoma (ESCC), one of the most common malignant tumors, is now afflicting approximately 80% of patients diagnosed with esophageal cancers. The therapeutic effect and prognosis of ESCC remain inadequate due to the unusual early symptoms and rapid malignant progression. SH2 Domain containing 4 A (SH2D4A) is downregulated in malignancies and is closely associated with tumor progression. However, neither the biological functions nor the fundamental mechanisms of SH2D4A on ESCC are known. In this study, it was found that SH2D4A is downregulated in ESCC tissues and cell lines. Incorporating immunohistochemistry and clinicopathological findings, we determined that decreased SH2D4A expression was substantially associated with adverse clinical outcomes. Overexpression of SH2D4A inhibited cell proliferation and migration, whereas suppressing SH2D4A has the opposite effect. SH2D4A mechanistically inhibited cells from proliferating and migrating through the FAK/PI3K/AKT signaling pathway. Furthermore, the results of xenograft tumor growth confirmed the preceding findings. In conclusion, our findings reveal that SH2D4A is a gene which can serve as a cancer suppressor in ESCC and may inhibits the ESCC progression by interfering with the FAK/PI3K/AKT signaling pathway. SH2D4A could act as a target for diagnostic or therapeutic purpose in ESCC.
Background: Thoracic acute aortic dissection (TAAD), one of the most fatal cardiovascular diseases, leads to sudden death, however, its mechanism remains unclear. Methods: Three Gene Expression Omnibus datasets were employed to detect differentially expressed genes (DEGs). A similar function and co-expression network was identified by weighted gene co-expression network analysis. The least absolute shrinkage and selection operator, random forest, and support vector machines-recursive feature elimination were utilized to filter diagnostic TAAD markers, and then screened markers were validated by quantitative real-time PCR and another independent dataset. CIBERSORT was deployed to analyze and evaluate immune cell infiltration in TAAD tissues. Results: Twenty-five DEGs were identified and narrowed down to three after screening. Finally, two genes, SLC11A1 and FGL2, were verified by another dataset and qRT-PCR. Function analysis revealed that SLC11A1 and FGL2 play significant roles in immune-inflammatory responses. Conclusion: SLC11A1 and FGL2 are differently expressed in aortic dissection and may be involved in immune-inflammatory responses.
The association between asthma and chronic obstructive pulmonary disease overlap (ACO) and insulin resistance (IR) has not been adequately investigated. Triglyceride glucose (TyG) index-related obesity indices offer a novel measure for assessing IR. We aimed to explore the associations between these indices and ACO in US population. Data used in this study were obtained from the National Health and Nutrition Examination Survey. We performed logistic regression analysis, restricted cubic spline modeling, subgroup analysis, sensitivity analysis, and additional analyses to examine the association between TyG-related obesity indices and ACO. The study involved 11,453 participants. TyG-waist to height ratio, TyG-body mass index, TyG-weight adjusted waist index, and TyG-waist circumference were all associated with ACO in multivariate logistic regression, with adjusted odds ratios (ORs) (95% confidence interval [CI]) of 1.23 (1.11–1.37), 1.32 (1.12–1.57), 1.20 (1.08–1.34), 1.14 (1.06–1.22), respectively. The highest quartile of all indices had the strongest link with ACO, as evidenced for TyG-waist to height ratio (OR [95% CI] = 1.80 [1.29–2.52]), TyG-body mass index (OR [95% CI] = 1.59 [1.19–2.14]), TyG-weight adjusted waist index (OR [95% CI] = 1.82 [1.23–2.69]), and TyG-waist circumference (OR [95% CI] = 1.75 [1.28–2.39]) in the fully adjusted model. Most subgroup, sensitivity, and supplementary analyses revealed similar results. TyG-related obesity indices were significantly associated with ACO. This finding indicates a strong correlation between high IR and susceptibility to ACO in the US population.
Background This study sought to analyze the correlation between oxidative balance score (OBS) and cardiometabolic risk factors (CMRFs) and mortality in individuals with CMRFs. Methods Data were chosen from the National Health and Nutrition Examination Survey. The survey-weighted multivariable logistic regression models were implemented to explore the relationship between OBS and the risk of CMRFs. Then, Cox proportional hazard models were employed to estimate the impact of OBS on mortality in individuals with CMRFs. Results Following multivariate adjustment, the subjects in the highest quartile exhibited a 46% reduction in the risk of CMRFs, a 33% reduction in the risk of diabetes, a 31% reduction in the risk of hypertension, and a 36% reduction in the risk of hyperlipidemia, compared with those in the lowest quartile. Furthermore, each 1-unit increase in OBS was remarkably negatively correlated with the prevalence of CMRFs, diabetes, hypertension, and hyperlipidemia. The correlation between OBS and CMFRs was found to be mediated by serum γ-glutamyltransferase (GGT) and white blood cells (WBC), and the mediation effect of GGT levels and WBC, accounting for 6.90% and 11.51%, respectively. Lastly, the multivariate Cox regression model revealed that elevated OBS, irrespective of whether it was treated as a categorical or continuous variable, exhibited a significant association with decreased mortality from all causes, cardiovascular disease, and cancer. Conclusions An increased OBS might reflect a lower risk of CMRFs and a favorable prognosis for individuals with CMRFs. Moreover, WBC and GGT may play a potential mediating role between OBS and CMRFs. What is new? An elevated OBS was correlated with a reduced risk of developing CMRFs. Furthermore, WBC and GGT could act as mediators in this association. An increased OBS might indicate a positive prognosis for individuals with CMRFs. What are the clinical implications?OBS might serve as a valuable tool to guide the general population toward adopting healthy diets and positive lifestyle patterns in order to mitigate the risk of CMRFs and enhance the prognosis of CMRFs individuals with CMRFs.